A detailed history of Sound View Wealth Advisors Group, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Sound View Wealth Advisors Group, LLC holds 1,164 shares of BIIB stock, worth $173,459. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,164
Holding current value
$173,459
% of portfolio
0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$189.07 - $236.8 $220,077 - $275,635
1,164 New
1,164 $225,000
Q4 2023

Feb 08, 2024

BUY
$222.59 - $267.94 $5,564 - $6,698
25 Added 2.15%
1,188 $307,000
Q3 2023

Nov 07, 2023

BUY
$253.3 - $285.89 $294,587 - $332,490
1,163 New
1,163 $298,000
Q1 2023

May 12, 2023

BUY
$256.56 - $292.34 $253,224 - $288,539
987 New
987 $274,000
Q4 2020

Feb 02, 2021

SELL
$236.26 - $355.63 $178,848 - $269,211
-757 Closed
0 $0
Q2 2020

Aug 07, 2020

BUY
$258.66 - $342.55 $195,805 - $259,310
757 New
757 $203,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Sound View Wealth Advisors Group, LLC Portfolio

Follow Sound View Wealth Advisors Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sound View Wealth Advisors Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sound View Wealth Advisors Group, LLC with notifications on news.